Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Fructose 1-phosphate is the one and only physiological effector of the Cra (FruR) regulator of Pseudomonas putida

M. Chavarría, G. Durante-Rodríguez, T. Krell, C. Santiago, J. Brezovsky, J. Damborsky, V. de Lorenzo,

. 2014 ; 4 (-) : 377-86.

Language English Country Netherlands

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc14064289

Fructose-1-phosphate (F1P) is the preferred effector of the catabolite repressor/activator (Cra) protein of the soil bacterium Pseudomonas putida but its ability to bind other metabolic intermediates in vivo is unclear. The Cra protein of this microorganism (Cra(PP)) was submitted to mobility shift assays with target DNA sequences (the PfruB promoter) and candidate effectors fructose-1,6-bisphosphate (FBP), glucose 6-phosphate (G6P), and fructose-6-phosphate (F6P). 1 mM F1P was sufficient to release most of the Cra protein from its operators but more than 10 mM of FBP or G6P was required to free the same complex. However, isothermal titration microcalorimetry failed to expose any specific interaction between Cra(PP) and FBP or G6P. To solve this paradox, transcriptional activity of a PfruB-lacZ fusion was measured in wild-type and ΔfruB cells growing on substrates that change the intracellular concentrations of F1P and FBP. The data indicated that PfruB activity was stimulated by fructose but not by glucose or succinate. This suggested that Cra(PP) represses expression in vivo of the cognate fruBKA operon in a fashion dependent just on F1P, ruling out any other physiological effector. Molecular docking and dynamic simulations of the Cra-agonist interaction indicated that both metabolites can bind the repressor, but the breach in the relative affinity of Cra(PP) for F1P vs FBP is three orders of magnitude larger than the equivalent distance in the Escherichia coli protein. This assigns the Cra protein of P. putida the sole role of transducing the presence of fructose in the medium into a variety of direct and indirect physiological responses.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14064289
003      
CZ-PrNML
005      
20140904113225.0
007      
ta
008      
140704s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.fob.2014.03.013 $2 doi
035    __
$a (PubMed)24918052
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Chavarría, Max $u Systems and Synthetic Biology Program, Centro Nacional de Biotecnología (CNB-CSIC), Cantoblanco, Madrid 28049, Spain ; Escuela de Química, Universidad de Costa Rica, 2060 San José, Costa Rica.
245    10
$a Fructose 1-phosphate is the one and only physiological effector of the Cra (FruR) regulator of Pseudomonas putida / $c M. Chavarría, G. Durante-Rodríguez, T. Krell, C. Santiago, J. Brezovsky, J. Damborsky, V. de Lorenzo,
520    9_
$a Fructose-1-phosphate (F1P) is the preferred effector of the catabolite repressor/activator (Cra) protein of the soil bacterium Pseudomonas putida but its ability to bind other metabolic intermediates in vivo is unclear. The Cra protein of this microorganism (Cra(PP)) was submitted to mobility shift assays with target DNA sequences (the PfruB promoter) and candidate effectors fructose-1,6-bisphosphate (FBP), glucose 6-phosphate (G6P), and fructose-6-phosphate (F6P). 1 mM F1P was sufficient to release most of the Cra protein from its operators but more than 10 mM of FBP or G6P was required to free the same complex. However, isothermal titration microcalorimetry failed to expose any specific interaction between Cra(PP) and FBP or G6P. To solve this paradox, transcriptional activity of a PfruB-lacZ fusion was measured in wild-type and ΔfruB cells growing on substrates that change the intracellular concentrations of F1P and FBP. The data indicated that PfruB activity was stimulated by fructose but not by glucose or succinate. This suggested that Cra(PP) represses expression in vivo of the cognate fruBKA operon in a fashion dependent just on F1P, ruling out any other physiological effector. Molecular docking and dynamic simulations of the Cra-agonist interaction indicated that both metabolites can bind the repressor, but the breach in the relative affinity of Cra(PP) for F1P vs FBP is three orders of magnitude larger than the equivalent distance in the Escherichia coli protein. This assigns the Cra protein of P. putida the sole role of transducing the presence of fructose in the medium into a variety of direct and indirect physiological responses.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Durante-Rodríguez, Gonzalo $u Systems and Synthetic Biology Program, Centro Nacional de Biotecnología (CNB-CSIC), Cantoblanco, Madrid 28049, Spain.
700    1_
$a Krell, Tino $u Department of Environmental Protection, Estación Experimental del Zaidín, CSIC, C/Profesor Albareda, Granada, Spain.
700    1_
$a Santiago, César $u X-ray Crystallography Unit, Centro Nacional de Biotecnología (CNB-CSIC), Cantoblanco, Madrid 28049, Spain.
700    1_
$a Brezovsky, Jan $u Loschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00 Brno, Czech Republic.
700    1_
$a Damborsky, Jiri $u Loschmidt Laboratories, Department of Experimental Biology and Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Kamenice 5/A13, 625 00 Brno, Czech Republic.
700    1_
$a de Lorenzo, Víctor $u Systems and Synthetic Biology Program, Centro Nacional de Biotecnología (CNB-CSIC), Cantoblanco, Madrid 28049, Spain.
773    0_
$w MED00184538 $t FEBS open bio $x 2211-5463 $g Roč. 4, č. - (2014), s. 377-86
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24918052 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20140904113619 $b ABA008
999    __
$a ind $b bmc $g 1031773 $s 863021
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 4 $c - $d 377-86 $i 2211-5463 $m FEBS open bio $n FEBS Open Bio $x MED00184538
LZP    __
$a Pubmed-20140704

Find record

Citation metrics

Archiving options